by HBOT News | Dec 14, 2015 | Cancer
Abstract: Lung cancer is the leading cause of cancer deaths worldwide; survival times are poor despite therapy. The role of the two-pore domain K+ (K2P) channel TASK-1 (KCNK3) in lung cancer is at present unknown. We found that TASK-1 is expressed in non-small cell...
by HBOT News | Dec 10, 2015 | Cancer
Abstract: Photodynamic therapy (PDT) is an established treatment modality for non-small cell lung cancer. Phototoxicity, the primary adverse event, is expected to be minimized with the introduction of new photosensitizers that have shown promising results in phase I...
by HBOT News | Dec 9, 2015 | Cancer
Abstract: Recent reports demonstrate that the expression of protein kinase C alpha (PKCα) in triple-negative breast cancer (TNBC) correlates with decreased survival outcomes. However, off-target effects of targeting PKCα and limited understanding of the signaling...
by HBOT News | Nov 23, 2015 | Carcinoma
Abstract: Head and neck cancer is often managed with a combination of surgery, radiation therapy, and chemotherapy, and skin toxicity is not uncommon. Xanthogranuloma is a pathological finding resulting from an inflammatory reaction that has not been previously...
by HBOT News | Oct 2, 2015 | Cancer
Abstract: This study identified predictors of high-grade late hematochezia (HH) following 5-fraction gantry-based stereotactic ablative radiation therapy (SABR). Hematochezia data for 258 patients who received 35 to 40 Gy SABR in 5-fractions as part of sequential...
